D-dimer landmark trials

D-Dimer Microchapters
Home
Patient information
Overview
Historical Perspective
Physiology
Clinical Correlation
Causes of High D-dimer
Diagnostic Role in Thromboembolism
Prognostic Role in Mortality
Prognostic Role in Thromboembolism Occurence
Prognostic Role in Thromboembolism Recurrence
Prognostic Role in Non-Thromboembolism
Clinical Trials
Landmark Trials
Case #1
D-dimer landmark trials On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of D-dimer landmark trials All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on D-dimer landmark trials
CDC on D-dimer landmark trials
D-dimer landmark trials in the news
Blogs on D-dimer landmark trials
Directions to Hospitals Treating D-dimer
Risk calculators and risk factors for D-dimer landmark trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

PROLONG Study

PROLONG-II Study

The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study

VAPRED Study

Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial

PREVENT